Aurinia Pharmaceuticals AUPH Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's other working capital?
- Aurinia Pharmaceuticals (AUPH) reported other working capital of -$581K in Q1 2026.
- How has Aurinia Pharmaceuticals's other working capital changed year-over-year?
- Aurinia Pharmaceuticals's other working capital increased by 75.0% year-over-year, from -$2.33M to -$581K.
- What is the long-term trend for Aurinia Pharmaceuticals's other working capital?
- Over 2 years (2021 to 2025), Aurinia Pharmaceuticals's other working capital has grown at a 900.0% compound annual growth rate (CAGR), from $2K to $200K.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.